OraSure Technologies Inc (OSUR)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

$2.42

Buy

$2.65

arrow-down$-0.08 (-3.11%)

Prices updated at 13 Dec 2025, 00:46 EST
| Prices minimum 15 mins delay
|
Prices in USD

OraSure Technologies Inc develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Mr. John Patrick Kenny
CEO
Ms. Carrie Eglinton Manner
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
501
Head office
220 East First Street
Bethlehem
United States
18015
mobile
+1 610 882-1820
letter
investorinfo@orasure.com

Key personnel

Salary
Mr. John Patrick Kenny
Chairman of the Board
-
Mr. Steven K. Boyd
Independent Director
-
Mr. Robert W. McMahon
Independent Director
0.08m
Ms. Carrie Eglinton Manner
Director, President and Chief Executive Officer
0.72m
Ms. Michele Anthony
Senior Vice President, Controller and Chief Accounting Officer
-
Dr. David J. Shulkin, M.D.
Independent Director
0.07m
Mr. Lelio Marmora
Independent Director
0.07m
Dr. Nancy J. Gagliano, M.D.
Independent Director
0.09m
Mr. Kenneth J. McGrath
Chief Financial Officer
0.50m

Top 5 shareholders

No. of shares
BlackRock Inc6,708,884
Private Management Group Inc5,417,289
Vanguard Group Inc4,252,430
Vanguard Group Inc. ( Junked)4,381,276
Neuberger Berman Investment Advisers LLC4,203,838

Director dealings

Action
08 Aug 2024-
04 Jun 2024-
14 May 2024-
14 May 2024-
14 May 2024-
14 May 2024-
14 May 2024-
14 May 2024-
14 May 2024-
14 May 2024-
14 May 2024-
26 Mar 2024-
26 Mar 2024-
01 Mar 2024-
01 Mar 2024-
01 Mar 2024-
01 Mar 2024-
01 Mar 2024-
01 Mar 2024-
01 Mar 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.